Romina Brignardello-Petersen

Romina Brignardello-Petersen

Auto-generated profile, based on publicly available information

Romina Brignardello-Petersen

Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Ontario, Canada

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
ABAshley Bonner
Ashley Bonner
PAPaul E. Alexander
Paul E. Alexander
RSReed A. Siemieniuk
Reed A. Siemieniuk
TFToshi A. Furukawa
Toshi A. Furukawa
Gordon H. GuyattGordon H. Guyatt
Gordon H. Guyatt

12 January 2021 in Blood Advances
Verified
Journal Article
Closed access
NCNathan T. Connell
Nathan T. Connell
VFVeronica H. Flood
Veronica H. Flood
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
RARezan Abdul-Kadir
Rezan Abdul-Kadir
AAAlice Arapshian
Alice Arapshian
RMReem A. Mustafa
Reem A. Mustafa
Background: von Willebrand disease (VWD) is a common inherited bleeding disorder. Significant variability exists in management options offered to patients.Objective: These evidence-based guidelines from the American Society of Hematology (ASH), the International Society on Thrombosis and Haemostasis (ISTH), the National Hemophilia Foundation (NHF), and the World Federation of Hemophilia (WFH) are intended to support patients, clinicians, and health care professionals in their decisions about management of VWD.Methods: ASH, ISTH, NHF, and WFH formed a multidisciplinary guideline panel. Three patient representatives were included. The panel was balanced to minimize potential bias from conflicts of interest. The University of Kansas Outcomes and Implementation Research Unit and the McMaster Grading of Recommendations Assessment, Development and Evaluation (GRADE) Centre supported the guideline development process, including performing and updating systematic evidence reviews (through November 2019). The panel prioritized clinical questions and outcomes according to their importance to clinicians and patients. The panel used the GRADE approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.Results: The panel agreed on 12 recommendations and outlined future research priorities.Conclusions: These guidelines make key recommendations regarding prophylaxis for frequent recurrent bleeding, desmopressin trials to determine therapy, use of antiplatelet agents and anticoagulant therapy, target VWF and factor VIII activity levels for major surgery, strategies to reduce bleeding during minor surgery or invasive procedures, management options for heavy menstrual bleeding, management of VWD in the context of neuraxial anesthesia during labor and delivery, and management in the postpartum setting.

8 February 2021 in Blood Advances
Verified
Journal Article
Open access
PDF file
ACAdam Cuker
Adam Cuker
ETEric K. Tseng
Eric K. Tseng
RNRobby Nieuwlaat
Robby Nieuwlaat
PAPantep Angchaisuksiri
Pantep Angchaisuksiri
CBClifton Blair
Clifton Blair
HSHolger J. Schünemann
Holger J. Schünemann
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness are associated with a risk of venous thromboembolism (VTE).Objective: These evidence-based guidelines of the American Society of Hematology (ASH) are intended to support patients, clinicians, and other health care professionals in decisions about the use of anticoagulation for thromboprophylaxis for patients with COVID-19–related critical illness and acute illness who do not have confirmed or suspected VTE.Methods: ASH formed a multidisciplinary guideline panel and applied strict management strategies to minimize potential bias from conflicts of interest. The panel included 3 patient representatives. The McMaster University GRADE Centre supported the guideline-development process, including performing systematic evidence reviews (up to 19 August 2020). The panel prioritized clinical questions and outcomes according to their importance for clinicians and patients. The panel used the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach, including GRADE Evidence-to-Decision frameworks, to assess evidence and make recommendations, which were subject to public comment.Results: The panel agreed on 2 recommendations. The panel issued conditional recommendations in favor of prophylactic-intensity anticoagulation over intermediate-intensity or therapeutic-intensity anticoagulation for patients with COVID-19–related critical illness or acute illness who do not have confirmed or suspected VTE.Conclusions: These recommendations were based on very low certainty in the evidence, underscoring the need for high-quality, randomized controlled trials comparing different intensities of anticoagulation. They will be updated using a living recommendation approach as new evidence becomes available.

11 November 2020 in BMJ
Verified
Journal Article
Closed access
PDF file
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
IFIvan D Florez
Ivan D Florez
AIAriel Izcovich
Ariel Izcovich
NSNancy Santesso
Nancy Santesso
GHGlen Hazlewood
Glen Hazlewood
GGGordon H Guyatt
Gordon H Guyatt
This article describes GRADE (grading of recommendations assessment, development and evaluation) guidance on how to draw conclusions from a network meta-analysis of interventions that includes individual randomised controlled trials addressing a single outcome. The guidance uses a minimally contextualised approach that avoids value judgments regarding the magnitude of intervention effects. The framework is based on two principles: interventions should be grouped in categories, from the most to the least effective or harmful; and the judgments that place interventions in such categories should simultaneously consider the estimates of effect, the certainty of the evidence, and the rankings. The framework includes five steps, which we describe and illustrate using an example. The framework is simple, methodologically sound, and flexible, allowing for modifications to resolve situations in which additional complexity or value judgments might be appropriate.

1 April 2019 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
RMReem A. Mustafa
Reem A. Mustafa
RSReed A.C. Siemieniuk
Reed A.C. Siemieniuk
MMM. Hassan Murad
M. Hassan Murad
TAThomas Agoritsas
Thomas Agoritsas
GGGordon H. Guyatt
Gordon H. Guyatt

20 July 2024 in American Journal of Epidemiology
Verified
Journal Article
Open access
PDF file
RBRomina Brignardello-Petersen
Romina Brignardello-Petersen
NSNancy Santesso
Nancy Santesso
Gordon H GuyattGordon H Guyatt
Gordon H Guyatt
Systematic reviews are a type of evidence synthesis in which authors develop explicit eligibility criteria, collect all the available studies that meet these criteria, and summarize results using reproducible methods that minimize biases and errors. Systematic reviews serve different purposes and use a different methodology than other types of evidence synthesis such as narrative reviews, scoping reviews, and overviews of reviews. Systematic reviews can address questions regarding effects of interventions or exposures, diagnostic properties of tests, and prevalence or prognosis of diseases. All rigorous systematic reviews have common processes that include (1) determining the question and eligibility criteria, including a priori specification of subgroup hypotheses, (2) searching for evidence and selecting studies, (3) abstracting data and assessing risk of bias of the included studies, (4) summarizing the data for each outcome of interest, whenever possible using meta-analyses, and (5) assessing the certainty of the evidence and drawing conclusions. There are several tools that can guide and facilitate the systematic review process, but methodological and content expertise are always necessary.